Tamoxifen Citrate in 2025: Continued Relevance in Oncology and Beyond Tamoxifen Citrate, a well-established drug in the fight against breast cancer, remains a cornerstone of treatment even as oncology evolves rapidly in 2025. Originally approved decades ago, tamoxifen’s role as a selective estrogen receptor modulator (SERM) continues to provide life-saving benefits for millions...